ArticleAlzheimer's & dementia (New York, N. Y.)
The HOPE4MCI study: AGB101 treatment slows progression of entorhinal cortex atrophy in
Arnold Bakker et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
pooled itcites it